Abstract:Tumor-associated macrophages (TAMs) are the most widely infiltrating immune cells in the tumor microenvironment (TME). Clinically, the number of TAMs is closely correlated with poor outcomes in multiple cancers. The biological actions of TAMs are complex and diverse, including mediating angiogenesis, promoting tumor invasion and metastasis, and building an immunosuppressive microenvironment. Given these pivotal roles of TAMs in tumor development, TAM-based strategies are attractive and used in certain tumor therapies, including inhibition of angiogenic signalling, blockade of the immune checkpoint, and macrophage enhancement phagocytosis. Several attempts to develop TAM-targeted agents have been made to deplete TAMs or reprogram the behaviour of TAMs. Some have shown a favourable curative effect in monotherapy, combination with chemotherapy or immunotherapy in clinical trials. Additionally, a new macrophage-based cell therapeutic technology was recently developed by equipping macrophages with CAR molecules. It is expected to break through barriers to solid tumor treatment. Although TAM-related studies have yielded positive antitumor outcomes, further investigations are needed to better characterize TAMs, which will benefit further establishment of novel strategies for tumor therapy. Here, we concisely summarize the functions of TAMs in the TME and comprehensively introduce the latest TAM-based regimens in cancer treatment.

Targeting Tumor-Associated Macrophages in Cancer Immunotherapy

Tumor-Associated Macrophages in Tumor Immunity (vol <i>11</i>, <i>583084</i>, <i>2020</i>)

Targeting Tumor-Associated Macrophages As an Antitumor Strategy.

Immunotherapies Targeting Tumor-Associated Macrophages (TAMs) in Cancer

Targeting tumor-associated macrophages for cancer treatment

Tumor-Associated Macrophages: A Potential Target For Cancer Therapy

Targeting immune checkpoints on tumor-associated macrophages in tumor immunotherapy.

Tumor-associated macrophages: A promising target for a cancer immunotherapeutic strategy

Tumor‐associated Macrophages in Immunotherapy

Targeting tumor-associated macrophages to synergize tumor immunotherapy

Targeting tumor‑associated macrophages: Critical players in tumor progression and therapeutic strategies (Review)

Decoding the spatiotemporal heterogeneity of tumor-associated macrophages

Roles of Tumor-Associated Macrophages in Tumor Environment and Strategies for Targeting Therapy

Harnessing Tumor-Associated Macrophages As Aids for Cancer Immunotherapy

Tumor-Associated Macrophages as Major Immunosuppressive Cells in the Tumor Microenvironment

Tumor-Associated Macrophages in Tumor Immunity

Tumor-associated macrophages: potential therapeutic strategies and future prospects in cancer

The Crosstalk Between Tumor-Associated Macrophages (TAMs) and Tumor Cells and the Corresponding Targeted Therapy

Tumor-Associated Macrophages: Recent Insights and Therapies

Research Progress on the Role of Tumor‑associated Macrophages in Tumor Development and Their Use As Molecular Targets (Review).

Therapeutic Approaches Targeting Proteins in Tumor-Associated Macrophages and Their Applications in Cancers